Purification, Cloning, and Characterization of the 16 S RNA m2G1207 Methyltransferase from Escherichia coli*

Joan S. TscherneDagger , Kelvin Nurse§, Paul Popienick, and James Ofengandparallel

From the Department of Biochemistry and Molecular Biology, University of Miami School of Medicine, Miami, Florida 33101

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The methyltransferase that forms m2G1207 in Escherichia coli small subunit rRNA has been purified, cloned, and characterized. The gene was identified from the N-terminal sequence of the purified enzyme as the open reading frame yjjT (SWISS-PROT accession number P39406). The gene, here renamed rsmC in view of its newly established function, codes for a 343-amino acid protein that has homologs in prokaryotes, Archaea, and possibly also in lower eukaryotes. The enzyme reacted well with 30 S subunits reconstituted from 16 S RNA transcripts and 30 S proteins but was almost inactive with the corresponding free RNA. By hybridization and protection of appropriate segments of 16 S RNA that had been extracted from 30 S subunits methylated by the enzyme, it was shown that of the three naturally occurring m2G residues, only m2G1207 was formed. Whereas close to unit stoichiometry of methylation could be achieved at 0.9 mM Mg2+, both 2 mM EDTA and 6 mM Mg2+ markedly reduced the level of methylation, suggesting that the optimal substrate may be a ribonucleoprotein particle less structured than a 30 S ribosome but more so than free RNA.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The modified nucleosides of RNA remain one of the enigmas of RNA biology. Despite being widely distributed among all classes of RNA in a bewildering plethora of shapes and forms (1), little or no functional role, and certainly no unifying concept, has yet to emerge. Although certain modulating effects on cellular processes have been described, usually under special circumstances and so far only in tRNA (2), no modified nucleoside has yet been shown to be of major importance for cell growth and/or survival. In rRNA, which next to tRNA contains the widest known assortment of modified nucleosides, no function has so far been ascribed to them, although a potential role in peptide bond formation for a subset of the modified nucleosides of Escherichia coli 23 S RNA has been postulated (3). In E. coli 16 S RNA, in which all of the modified nucleosides are known and their locations precisely determined, none was essential for any of the known ribosomal functions, although ribosomal efficiency was reduced to approximately half when all were absent (4, 5). Evidence has been presented that this lowered efficiency of the 30 S subunits may be attributable to the lack of one or more of the 10 methylated residues and/or the single pseudouridine (6) in the RNA (7).

To explore the role of individual modified nucleosides of 16 S RNA in 30 S subunit structure and function, a way is needed to specifically block their formation, one at a time. The most straightforward way to do this is by inactivating the enzymes responsible for their synthesis by gene deletion or disruption, because mutation of the parent nucleoside in the RNA could have unforeseen consequences. So far, three genes and enzymes for the modified nucleosides of E. coli 16 S RNA have been described. The first, rsmA (more commonly known as ksgA), makes the two m26A residues at positions 1518 and 1519 (8). Loss of these four methyl groups has little effect on ribosome function (9). The synthase for the single pseudouridine at position 516 (6) has been deleted,1 and the cell still grows well, although precise growth rates have not yet been determined. A methyltransferase that specifically forms m5C967 has recently been described,2 but results of deletion experiments are not yet available. In this work, we describe the characterization of another methyltransferase, that for m2G1207. The gene was identified by N-terminal amino acid sequence analysis of the isolated enzyme and confirmed by overexpression with a His tag, affinity purification, and in vitro biochemical characterization.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Materials-- [3H]S-Adenosyl-methionine ([3H]-SAM)3 was from Amersham Pharmacia Biotech. Plasmid pET-15b, the BL21/DE3 strain of E. coli, and His-Bind resin were from Novagen, Inc. The XL1-Blue Epicurian strain of E. coli was from Stratagene. RNase T1 was from Calbiochem, and RNase P1 was obtained from Life Technologies, Inc. DNase I was from Worthington. T4 DNA ligase and restriction enzymes were from New England Biolabs. Wizard DNA purification kits and RNasin were from Promega. BA85 cellulose nitrate filters were obtained from Schleicher & Schuell, polyvinylidene difluoride membranes were from Millipore, and omega cells were from Filtron. DEAE-Sepharose CL-6B and MonoS fast protein liquid chromatography columns were obtained from Amersham Pharmacia Biotech. Alumina type A-5 was from Sigma. Deoxyoligonucleotides for protection studies were those described previously (11). Polymerase chain reaction primers were prepared as described (12).

Buffers-- Buffer Ax is 20 mM Hepes, pH 7.5, 10 mM Mg(OAc)2, x mM NH4Cl, and 2 mM dithiothreitol. Buffer Bx is 20 mM Hepes, pH 7.5, 1 mM EDTA, x mM NH4Cl, and 2 mM dithiothreitol. Buffer C is 20 mM Hepes, pH 7.8, 20 mM NH4Cl, 5 mM mercaptoethanol (BME), 0.1 mM EDTA, and 10% glycerol. Buffer D is 20 mM Hepes, pH 8.0, 100 mM NH4Cl, 5 mM BME, 0.1 mM EDTA, and 6 M urea. Buffer LB is 50 mM Tris, pH 6.8, 100 mM dithiothreitol, 2% SDS, 10% glycerol, and 0.1% bromphenol blue. Binding Buffer is 20 mM Hepes, pH 7.9, 0.5 M NaCl, and 5 mM imidazole. Elution Buffer is Binding Buffer with the imidazole concentration raised to 1.0 M.

Purification of the m2G Methyltransferase-- The purification procedure was similar to that previously described (13, 14). One hundred grams of E. coli MRE600 cells harvested in mid-log phase were ground with 200 g of alumina. Then 3000 units of DNase I and 100 ml of Buffer A100 containing 0.2 mM phenylmethanesulfonyl fluoride were added. The mixture was incubated for 15 min at 0 °C and then centrifuged in a Sorvall SS-34 rotor for 30 min at 16,000 rpm yielding the S30. The S30 supernatant was centrifuged for 4 h at 30,000 rpm in a Beckman Ti45 rotor. The pellet was resuspended in 80 ml of Buffer A1000, underlayered with 40 ml of the same buffer plus 37% sucrose, and centrifuged at 45,000 rpm for 16-18 h using slow acceleration. The supernatant of this centrifugation is the high salt wash. The high salt wash was adjusted to 35% saturation (NH4)2SO4 and allowed to stir on ice for 4 h. The precipitate was removed by centrifugation, and the supernatant was dialyzed overnight against Buffer B50. The dialyzed sample was loaded onto a 5 × 43-cm DEAE-Sepharose CL-6B column equilibrated with Buffer B50 and eluted with a linear gradient of 50-500 mM NH4Cl in Buffer B0. The m2G methyltransferase activity eluted with a peak at 170 mM NH4Cl. The peak fractions were pooled, concentrated, and returned to Buffer B50 by omega cell filtration. The sample was loaded onto a 0.5 × 5-cm MonoS column, which had been equilibrated with Buffer B50. The column was eluted with a linear gradient from 50-1000 mM NH4Cl in Buffer B0. The methyltransferase activity eluted at 250 mM NH4Cl. The peak fractions were pooled and either used directly or made 50% in glycerol for storage at -20 °C.

Cloning and Overexpression of the m2G Methyltransferase Gene-- The putative gene was amplified by polymerase chain reaction. The N-terminal primer extended from -13 to +14, where A of the initiating ATG is +1, with changes at -1, -2, and -3 to create an NdeI site adjacent to the initiating ATG. The C-terminal primer, in the reverse orientation, extended from +1061 to +1087, where the last sense nucleotide is 1029, and contained mismatches at 1073 and 1074 to create a BamHI site. After polymerase chain reaction, the amplified product was isolated by agarose gel electrophoresis, extracted using the Wizard DNA purification kit, concentrated by membrane filtration (Amicon Microcon 100), and digested with NdeI and BamHI. The pET-15b vector, also digested with NdeI and BamHI, and the gene insert were ligated by standard methods using T4 DNA ligase. Transformation of XL1-Blue Epicurian cells was performed by standard methods. Plasmids from three clones containing the insert were transferred into BL21/DE3 cells.

For overexpression the transformed BL21/DE3 cells were grown in Luria-Bertani broth containing 50 µg/ml carbenicillin at 37 °C to an A600 of 0.7. Isopropyl-beta -D-thiogalactopyranoside at 1 mM was added to the culture, and incubation continued at 37 °C to an A600 of 1.4-1.8. Cells were recovered by centrifugation and frozen at -70 °C. For analysis of the whole cell contents, cells from 1 ml of culture were suspended in 0.03 ml of 10 mM Tris, pH 8, plus an equal volume of 2 × Buffer LB, heated to 100 °C for 5 min, and then chilled. For preparation of recombinant protein, cells from 100 ml of culture were washed in 10 mM Hepes, pH 7.5, and 0.17 M NaCl and sonicated in 6 ml of either 20 mM Tris, pH 8, 20 mM NH4Cl, 5 mM MgCl2, 0.1 mM EDTA, 5 mM BME, and 1 mM phenylmethanesulfonyl fluoride or Binding Buffer plus 1 mM phenylmethanesulfonyl fluoride. Both buffers gave equivalent results. The sonicated mixture was centrifuged at 15,000 × g to obtain the S15 supernatant and pellet fractions. The S15 pellet was dissolved in 6 ml of Buffer D or in Binding Buffer containing 6 M urea.

Affinity Purification-- The S15 supernatant was dialyzed against Binding Buffer immediately before application to a 2.5-ml column of His-Bind resin. When Binding Buffer was used in the sonication step, dialysis could be omitted. Conditions of preparation and operation of the His-Bind resin column were as described in the pET System Manual, 4th Ed. (Novagen). After addition of Elution Buffer, the tagged protein was released. The A280-containing fractions were pooled and dialyzed against Buffer C. The S15 pellet from the same culture was solubilized in Buffer D or Binding Buffer containing 6 M urea. When the pellet was solubilized in Buffer D, the solution was dialyzed versus Binding Buffer containing 6 M urea before being applied to a 2.5-ml His-Bind column equilibrated in the same buffer. Otherwise, it was applied directly after solubilization. Elution was with Elution Buffer plus 6 M urea. The pooled A280-containing fractions were dialyzed against Buffer D with decreasing concentrations of urea from 6 to 3 M at 1.0 M intervals and then from 3 to 0 M at 0.5 M intervals for 1 h each. Both protein solutions were adjusted to contain 50% glycerol and stored at -20 °C.

Methylase Assays-- Reaction mixtures contained 100 mM Hepes, pH 7.5, and 2 mM Mg(OAc)2 except where otherwise indicated, 200 mM NH4Cl, 5 mM dithiothreitol or BME, 2 µM [3H]SAM, 500 units/ml RNasin, and 100 nM 16 S RNA transcript (prepared as in Ref. 15) or 80 nM 30 S ribosomal subunits reconstituted from 16 S RNA transcripts and ribosomal proteins (4, 16), and enzyme as indicated. Incubation was at 37 °C. The reaction was stopped by the addition of ice-cold 5% trichloroacetic acid. After precipitation at 0 °C for 10 min, samples were collected on BA85 cellulose nitrate filters, the filters were dissolved in scintillation fluid, and the radioactivity was measured. One unit of activity equals 1 pmol of methyl incorporated in 30 min under the above conditions.

Nucleoside Analysis-- Recombinant m2G methyltransferase was used to 3H methylate 30 S particles as described above. 1.05 pmol of CH3/pmol of particles was obtained. After phenol extraction of the [3H]RNA, it was digested in a 250-µl incubation mixture containing 20 mM NaOAc, 0.5 mM ZnSO4, 40 pmol/ml carrier 16 S RNA, 80 µg/ml RNase P1, and 7.3 pmol/ml [3H]RNA for 2 h at 37 °C. 15.4 µl of 1 M Tris buffer, pH 8.0, and 5.4 units of bacterial alkaline phosphatase were added, the volume was adjusted to 275 µl, and the incubation continued for an additional 2 h at 37 °C. The reaction was stopped by the addition of acetic acid to a concentration of 27 mM. m2G was added as an internal standard, and the mixture was analyzed by HPLC (11).

Protection Studies-- [3H]Methyl-labeled 16 S RNA (0.36 pmol) was hybridized with a 50-fold excess of deoxyoligonucleotide in a 50-µl reaction mixture, which also contained 40 mM Mes, pH 6.4, 400 mM NaCl, 9 mM EDTA, and freshly deionized 80% (v/v) formamide. The samples were heat-denatured at 90 °C for 10 min and then placed at room temperature for 15 min. They were then diluted with 9 volumes of ice-cold RNase Buffer (10 mM Tris-HCl, pH 7.5, 300 mM NaCl, and 5 mM EDTA), and RNase T1 (0.2-1.8 Sankyo units) was added. The samples were digested for 30 min at 30 °C. Digestion was stopped by the addition of 9 volumes of cold 10% trichloroacetic acid. After 10 min on ice, the samples were filtered on BA85 cellulose nitrate filters, the filters were dissolved, and the samples were counted.

Other Methods-- N-terminal sequencing was performed on samples of the purified enzyme, which had been electrophoresed on SDS gels. The protein was electroblotted onto a polyvinylidene difluoride membrane following standard procedures (17), and N-terminal sequencing was performed as described previously (16). Protein content was assayed by a modified Bradford procedure (Bio-Rad protein assay, catalog number 500-006) using bovine serum albumin as standard. SDS gels were 12% polyacrylamide and contained 0.38 M Tris-HCl, pH 8.8, and 0.1% SDS. The 5% stacking gel contained 0.13 M Tris-HCl, pH 6.8, and 0.1% SDS. Samples were heated at 95 °C for 5 min in Buffer LB and then quenched on ice for 5 min before loading. Gels were stained with Coomassie Blue.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Purification of the Methyltransferase and Identification of the Gene-- Previous work from this laboratory had identified two E. coli 16 S RNA methyltransferases, one specific for m2G966 and another specific for m5C967 (11, 13, 14). The m2G966 enzyme reacted with unmodified 30 S subunits (11, 13) or unmodified 16 S RNA complexed with 30 S proteins S7 and S19 (14) but not with free 16 S RNA, whereas the m5C967 enzyme had the reciprocal specificity. The purpose of the present work was to identify and clone the gene for the m2G methyltransferase. Following a purification scheme similar, but not identical, to that previously used, a preparation that reacted with 30 S but not 16 S RNA was obtained. Gel electrophoresis showed a single strong band at ~37 kDa. N-terminal sequencing of this band yielded the following sequence: SAFTPASEVLLRHSDDFEQ. A search of the GenBank data base showed an exact match to ORF yjjT (SWISS-PROT accession number P39406). The calculated molecular mass was 37.6 kDa, in good agreement with the experimental value. The presence of a strong 7-nucleotide Shine-Dalgarno sequence 6 nucleotides upstream from the initiating ATG was observed.

Cloning of the Gene, Overexpression, and Affinity Purification-- The putative gene was cloned into pET-15b by standard methods. Induced cells containing clones with this insert produced large amounts of protein ~37 kDa in size, whereas no such band was visible in the pET control (data not shown). The overexpressed protein was distributed between the S15 supernatant fraction and S15 pellet. Distribution between these two fractions varied somewhat from preparation to preparation, and renaturation of the enzyme in the pellet produced variable results. Therefore, all experiments were conducted using the soluble supernatant fraction of the enzyme. This fraction was purified by affinity chromatography on a Ni2+-containing resin, because the overexpressed protein contained an N-terminal His tag. The eluted protein product gave a single band on gel electrophoresis at the expected size (data not shown). The finding of methyltransferase activity in the affinity-purified protein (see below) is definitive proof that the gene cloned is a methyltransferase gene.

Substrate and Product Specificity of the m2G Methyltransferase-- The overexpressed enzyme possessed the same preference for 30 S particles over free RNA as described previously (14) for the partially purified m2G966 methyltransferase (Fig. 1). The m2G enzyme was able to incorporate ~0.5 pmol of methyl groups/pmol of particles in 20 min, whereas 0.02 pmol of methyl groups was incorporated/pmol of free 16 S RNA in the same time interval. The nature of the methylated nucleoside was examined by HPLC. [3H]methyl 30 S ribosomes were prepared using the recombinant enzyme, and the 16 S RNA was isolated. After digestion to nucleosides with RNase P1 and alkaline phosphatase, the mixture was analyzed by HPLC (Fig. 2). A single peak containing 90% of the radioactivity loaded onto the column was eluted at the m2G position, as confirmed by its co-elution with the added internal marker of m2G (Fig. 2, arrow). These results confirm that the recombinant enzyme does catalyze formation of m2G in 16 S RNA.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 1.   Substrate Specificity of the recombinant m2G methyltransferase. In vitro transcripts of 16 S RNA (open circle ) and 30 S ribosomes (bullet ) reconstituted from this transcript and a complete set of 30 S ribosomal proteins were prepared, and methylation was measured as incorporation of 3H into a trichloroacetic acid precipitate. The concentrations of 16 S RNA and 30 S particles were 100 and 80 nM, respectively. The Mg2+ concentrations were 4 mM (open circle ) and 2 mM (bullet ). The purified enzyme protein concentration was 0.41 µg/ml.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 2.   Characterization of the methylation product of recombinant m2G methyltransferase. [3H]methyl-reconstituted 30 S ribosomes were prepared using [3H]methyl-labeled SAM and recombinant m2G methyltransferase. 1.05 pmol of CH3/pmol of 30 S were obtained. The RNA was extracted with phenol, isolated, digested with RNase P1 and alkaline phosphatase, and analyzed by HPLC. The position of the m2G added as an internal standard was determined by its UV absorption and is marked by the arrow.

Localization of the Site of Methylation-- E. coli16 S RNA contains three m2G residues, at positions 966, 1207, and 1516 (Ref. 18 and Fig. 3). To determine which G was methylated by the recombinant enzyme, hybridization-protection studies were conducted using deoxyoligomers that were complementary to the RNA sequence spanning each of the m2G sites (13). Oligomer 958 spanned the region from residue 958 to residue 977, which included m2G966; oligomer 1197 spanned the region from residue 1197 to residue 1216, including m2G1207; and oligomer 1506 spanned the region from residue 1506 to residue 1525, which included m2G1516 (Fig. 3). The m2G methyltransferase previously characterized was specific for G966 (13). Because the purification scheme for the native enzyme used in this work was similar, and the recombinant enzyme had the same substrate specificity, we supposed that the same methyltransferase had been cloned. Unexpectedly, the hybridization-protection experiment showed clearly that this was not the case (Fig. 4). Oligomer 958 was as ineffective in protecting the label in the RNA from RNase digestion as was oligomer 1506 or no oligomer. On the other hand, oligomer 1197 efficiently protected the RNA from degradation. To control for artifacts, the deoxyoligonucleotides used in this experiment were the identical preparations used previously (13). In that work, oligomer 1197 did not protect either the m2G- or m62A-containing RNAs. Therefore, its protection here cannot be attributable to some generalized inhibitory effect on RNase T1. In that work, oligomer 958 did protect both the m5C and m2G labels; thus its failure to protect here cannot be attributable to some failure of hybridization. Likewise, because oligomer 1506 did protect the m26A-containing RNA, its inactivity here cannot be attributable to a hybridization failure. We conclude from these results that the recombinant m2G methyltransferase described here specifically modifies G1207 rather than G966.


View larger version (45K):
[in this window]
[in a new window]
 
Fig. 3.   Location of the m5C, m2G, and m26A residues and the sites of complementary deoxyoligonucleotides used in the hybridization-protection experiments. The positions of m5C, m2G, and m26A (arrows) are shown superimposed on the secondary structure of E. coli 16 S RNA (19). The segments of RNA complementary to the deoxyoligomers used in the hybridization-protection experiments are boxed.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 4.   Localization of the site of m2G formation by the recombinant methyltransferase. [3H]Methyl 16 S RNA (0.36 pmol) extracted from 30 S ribosomes that had been labeled (1.05 pmol of CH3/pmol of 30 S) using the recombinant m2G methyltransferase was hybridized with the indicated oligonucleotide and then digested with RNase T1 (0.2-1.8 Sankyo units) as described under "Experimental Procedures." bullet , oligomer 1197-1216; black-triangle, oligomer 958-977A; triangle , oligomer 958-977B; black-square, oligomer 1506-1525; open circle , no oligomer. Oligomer 958-977A was a fresh dilution from the original stock solution (11), and oligomer 958-977B was the same dilution used previously (11, 13).

Mg2+ Dependence of the m2G Methyltransferase-- Because of the fact that this methyltransferase recognized 30 S ribosomes but not free RNA, we expected that Mg2+ would be required for this reaction, even though a similar methyltransferase specific for m5C967 and for 16 S RNA functioned equally well in 1 mM EDTA as in 10 mM Mg2+.2 Moreover, because the m2G966 methyltransferase studied previously was inhibited in its methylation of 30 S subunits by increasing concentrations of Mg2+ (14), we tested two concentrations, 0.9 mM, which should cause partial unfolding of the particle, and 6 mM, which is known to be sufficient to stabilize natural 30 S particles in this buffer. Fig. 5 shows that at the lower Mg2+ concentration, methylation approaches unit stoichiometry (0.93 mol/mol), whereas at 6 mM Mg2+, the reaction levels off at ~0.3 mol of methyl/mol of ribosomes. Some Mg2+ is required, however, because in other experiments, 2 mM EDTA decreased the plateau level from 0.74 mol of methyl incorporated/mol of 30 S in 0.9 mM Mg2+ to 0.14 mol/mol in EDTA. In these experiments, the substrate was not preincubated under the specified Mg2+ conditions before the methylation reaction was initiated. In a single preincubation experiment in which the ribosomes were incubated in reaction buffer without SAM for 10 min at 37 °C before initiation of the reaction with SAM, the presence of 2 or 10 mM EDTA reduced incorporation levels further to 0.1 or <0.1 mol of methyl/mol of ribosomes, respectively, whereas the control in 0.9 mM Mg2+ still yielded 0.8 mol/mol.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 5.   Mg2+ dependence of methylation by the recombinant m2G methyltransferase. Methylation of reconstituted 30 S ribosomes was conducted as described under "Experimental Procedures," except that the incubation contained 0.9 (bullet ) or 6 (open circle ) mM Mg2+. The 30 S ribosome concentration was 40 nM and the purified enzyme concentration was 0.45 µg/ml.


    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Substrate Specificity and Mg2+ Requirements of the Enzyme-- Because the m2G1207 methyltransferase reacts with 30 S particles but barely at all with 16 S RNA, it seems likely that methylation of the G residue occurs after the 16 S RNA has associated with some ribosomal proteins. The m2G966 methyltransferase, which has similar specificity, has been shown to only require the presence of proteins S7 and S19 with the 16 S RNA to be recognized by the enzyme (14). Whether the m2G1207 methyltransferase can also efficiently recognize 16 S RNA complexed with only a few ribosomal proteins, and what these proteins are, must await further study.

The Mg2+ requirements for methylation are also consistent with the hypothesis that G1207 is methylated after the association of an unspecified number of ribosomal proteins but before assembly of the 30 S subunit is complete. At 0.9 mM Mg2+, virtually all of the G1207 residues in the 30 S subunit were available for reaction, whereas when the Mg2+ concentration was raised to 6 mM, only <FR><NU>1</NU><DE>3</DE></FR> were still available. On the other hand, in EDTA, only <FR><NU>1</NU><DE>7</DE></FR> were reactive, and preincubation reduced that amount to less than <FR><NU>1</NU><DE>10</DE></FR>. The structure of the 30 S particle at 0.9 mM Mg2+ is probably partially disordered and thus may mimic the structure of the ribonucleoprotein intermediate, which may be the true substrate. In EDTA, this structure may be lost, and at 6 mM Mg2+, the 30 S particle may be too compact for reactivity. The observed partial reaction at 6 mM Mg2+ may be attributable to the fact that 30 S ribosomes assembled from an RNA transcript are less stable than ones reconstituted from natural RNA (4, 16). We emphasize a role for Mg2+ in maintaining the proper substrate structure rather than a role at the catalytic center of the enzyme solely by analogy with the m5C967 methyltransferase, which had no Mg2+ requirement.2 Clearly, the current experiments do not allow us to distinguish between the two possibilities.

The substrate preference for 30 S ribosomes versus free RNA shown here for the m2G1207 enzyme and previously for the m2G966 methyltransferase (13, 14) is shared by the KsgA enzyme, which also requires a 30 S subunit for reaction (20). Perhaps the ability of the m5C967 methyltransferase to react with free RNA, but not with 30 S subunits, is the exception to the rule, and most or all of the other 16 S RNA-modifying enzymes require either a ribonucleoprotein or a complete 30 S subunit. RsuA, which makes the single pseudouridine in 16 S RNA, also has a specific requirement for a particular RNP particle (15).

How did two similar purification procedures yield an m2G966 enzyme previously and an m2G1207 enzyme in the current work? We suspect this occurred during the DEAE column purification step. Previously the eluate was only assayed with free RNA in the belief that the m2G activity, measured using 30 S subunits, co-purified at that step with the m5C activity assayed with free RNA. However, in the present work the DEAE eluate was assayed directly with 30 S. It is possible that the m2G966 enzyme was overlooked in the latter case, and in the former that the m2G1207 enzyme did not exactly co-purify with the m5C enzyme. Whatever the explanation, the sequenced protein identified the only ORF in E. coli with that N-terminal sequence, and this proved to be the m2G1207 methyltransferase.

Gene and Protein Sequence-- The gene coding for the m2G1207 methyltransferase is yjjT. This ORF codes for a 343-amino acid protein with a calculated molecular mass, 37.6 kDa, that agrees well with the value of 37 kDa for the native enzyme. We propose that the ORF be renamed rsmC for (r)ibosomal (s)mall subunit (m)ethyltransferase, because the function of the gene product has been identified as the enzyme for formation of m2G1207. C denotes that this is the third gene sequence for an rRNA methyltransferase to be described, the first one being ksgA, the gene for the m26A methyltransferase (8), and the second one being rsmB, the gene for the m5C967 methyltransferase.2 In keeping with this nomenclature, we suggest that rsmA would be a suitable alternate name for ksgA.

The RsmC sequence contains the SAM-binding motif DXGXGXGXL (21) at residues 201-209 as well as the somewhat longer motif in which this is embedded, which has been described by Koonin et al. (22) at residues 199-215. A search of the GenBank data base using BLAST 2.0.4 (23) identified proteins with highly significant similarity to the m2G1207 methyltransferase in seven organisms. These included the prokaryotes E. coli, Hemophilus influenzae, Bacillus subtilis, Staphyloccus aureus, and even the extremely divergent Thermotoga neapolitana as well as the archaebacteria Pyrococcus horikoshii and Methanococcus jannaschii. Somewhat less related were proteins from Streptomyces anulatus, Streptomyces pristinaespiralis, and Chlamydia trachomatis. No strong similarities were found with any higher eukaryotic ORFs.

The protein most similar in sequence to RsmC according to this analysis is from H. influenzae (P44453, HI0012). This protein is 330 amino acids long compared with 342 for RsmC. They are 46% identical and 65% similar along 328 residues. Given the high level of similarity between the two sequences, it is reasonable to suppose that this gene codes for an equivalent methyltransferase in H. influenzae and, therefore, that this organism also has an equivalently located m2G in its 16 S RNA. No information is available as to the presence of such an m2G in H. influenzae or for that matter in any of the other prokaryotes or archaebacteria. The next most similar amino acid sequence to RsmC is the hypothetical protein product of the E. coli ygjO gene. This 43.4-kDa protein is 33% identical and 50% similar over 173 residues to RsmC. We suspect that this protein is the m2G966 methyltransferase that we described previously (13, 14).

Role of Methylation of G1207 in the Ribosome-- m2G1207 is located in the helix 34 stem (see Fig. 3) in a region believed to be involved in recognition of peptide chain termination codons (24, 25). This region has been directly linked to the decoding site on the ribosome by cross-links from U1052, which is adjacent to m2G1207 on the opposite strand to the A site codon of mRNA (26) and from A1196, 11 nucleotides away on the same strand, to the next downstream mRNA codon (10). However, no specific role for m2G1207 is known in chain termination or codon recognition or, for that matter, in any other function of the ribosome. Moreover, it cannot be essential for ribosome function because, as noted in the introduction, functional 30 S ribosomes have been prepared lacking all modified nucleosides. However, as also noted there, the assembly ability as well as function relative to modified controls was reduced.

To study the reasons for this reduction in assembly and function, we have embarked on a program to identify all of the genes responsible for the modifying enzymes that act on E. coli 16 S RNA. So far, we have identified three such genes, rsuA (15), rsmB,2 and in this work, rsmC. rsmA (ksgA) was already known (8). There should be at most seven more genes to identify. Two putative genes have already been identified by their strong sequence similarity to RsmB and RsmC, respectively. Gene inactivation, one or more at a time, to block selected modifications should then help unravel the mystery of what modified nucleosides do in the ribosome.

    FOOTNOTES

* This work was supported by funds from Hoffmann-La Roche, Inc., and a Markey Foundation grant to the Department of Biochemistry and Molecular Biology, University of Miami School of Medicine. Experimental work was performed at the now defunct Roche Institute of Molecular Biology.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Present address: Dept. of Science and Technology, Bergen Community College, Paramus, NJ 07652.

§ Present address: RNA Research Group, Dept. of Molecular Recognition, Smithkline Beecham Pharmaceuticals, 709 Swedeland Rd., King of Prussia, PA 19406.

Present address: Tarrant County College, Arlington, TX 76018.

parallel To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, University of Miami School of Medicine, Miami, FL 33101. Tel.: 305-243-3677; Fax: 305-243-3955.

The abbreviations used are: SAM, S-adenosyl-methionine; HPLC, high performance liquid chromatography; ORF, open reading frame; Mes, 4-morpholineethanesulfonic acid.

1 L. Niu and J. Ofengand, unpublished results.

2 J. S. Tscherne, K. Nurse, P. Popienick, H. Michel, M. Sochacki, and J. Ofengand, submitted for publication.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. McCloskey, J. A., and Crain, P. F. (1998) Nucleic Acids Res. 26, 196-197[Abstract/Free Full Text]
  2. Björk, G. R. (1996) in Escherichia coli and Salmonella. Cellular and Molecular Biology (Neidhardt, F. C., Curtis, R., III, Ingraham, J. L., Lin, E. C. C., Low, K. B., Magasanik, B., Reznikoff, W. S., Riley, M., Schaechter, M., and Umbarger, H. E., eds), 2nd Ed., pp. 861-886, ASM Press, Washington, D. C.
  3. Green, R., and Noller, H. F. (1996) RNA 2, 1011-1021[Abstract]
  4. Krzyzosiak, W., Denman, R., Nurse, K., Hellmann, W., Boublik, M., Gehrke, C. W., Agris, P. F., and Ofengand, J. (1987) Biochemistry 26, 2353-2364[Medline] [Order article via Infotrieve]
  5. Denman, R., Nègre, D., Cunningham, P. R., Nurse, K., Colgan, J., Weitzmann, C., and Ofengand, J. (1989) Biochemistry 28, 1012-1019[Medline] [Order article via Infotrieve]
  6. Bakin, A., Kowalak, J. A., McCloskey, J. A., and Ofengand, J. (1994) Nucleic Acids Res. 22, 3681-3684[Abstract]
  7. Cunningham, P. R., Richard, R. B., Weitzmann, C. J., Nurse, K., and Ofengand, J. (1991) Biochimie 73, 789-796[CrossRef][Medline] [Order article via Infotrieve]
  8. Van Buul, C. P. J. J., and van Knippenberg, P. H. (1985) Gene (Amst.) 38, 65-72[CrossRef][Medline] [Order article via Infotrieve]
  9. Van Knippenberg, P. H. (1986) in Structure, Function, and Genetics of Ribosomes (Hardesty, B., and Kramer, G., eds), pp. 412-424, Springer-Verlag, Berlin
  10. Sergiev, P., Lavrik, I., Wlasoff, V., Dokudovskaya, S., Dontsova, O., Bogdanov, A., and Brimacombe, R. (1997) RNA 3, 464-475[Abstract]
  11. Nègre, D., Weitzmann, C., and Ofengand, J. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 4902-4906[Abstract]
  12. Bakin, A., and Ofengand, J. (1993) Biochemistry 32, 9754-9762[Medline] [Order article via Infotrieve]
  13. Nègre, D., Weitzmann, C., and Ofengand, J. (1990) in UCLA Symposia on Molecular and Cellular Biology New Series: Nucleic Acid Methylation (Clawson, G. A., Willis, D. B., Weissbach, A., and Jones, P. A., eds), Vol. 128, pp. 1-17, Wiley-Liss, New York
  14. Weitzmann, C., Tumminia, S., Boublik, M., and Ofengand, J. (1991) Nucleic Acids Res. 19, 7089-7095[Abstract]
  15. Wrzesinski, J., Bakin, A., Nurse, K., Lane, B. G., and Ofengand, J. (1995) Biochemistry 34, 8904-8913[Medline] [Order article via Infotrieve]
  16. Denman, R., Weitzmann, C., Cunningham, P. R., Nègre, D., Nurse, K., Colgan, J., Pan, Y.-C., Miedel, M., and Ofengand, J. (1989) Biochemistry 28, 1002-1011[Medline] [Order article via Infotrieve]
  17. Matsudaira, P. (1987) J. Biol. Chem. 262, 10035-10038[Abstract/Free Full Text]
  18. Rauè, H. A., Klootwijk, J., and Musters, W. (1988) Prog. Biophys. Mol. Biol. 51, 77-129[CrossRef][Medline] [Order article via Infotrieve]
  19. Stern, S., Powers, T., Changchien, L.-M., and Noller, H. F. (1989) Science 44, 783-790
  20. Poldermans, B., Roza, L., and Van Knippenberg, P. H. (1979) J. Biol. Chem. 254, 9094-9100[Medline] [Order article via Infotrieve]
  21. Ingrosso, D., Fowler, A. V., Bleibaum, J., and Clarke, S. (1989) J. Biol. Chem. 264, 20131-20139[Abstract/Free Full Text]
  22. Koonin, E. V., Tatusov, R. L., and Rudd, K. E. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 11921-11925[Abstract]
  23. Altschul, S. F., Madden, T. L., Schäffer, A. A., Zhang, J., Zhang, Z., Miller, W., and Lipman, D. J. (1997) Nucleic Acids Res. 25, 3389-3402[Abstract/Free Full Text]
  24. Moine, H., and Dahlberg, A. E. (1994) J. Mol. Biol. 243, 402-412[CrossRef][Medline] [Order article via Infotrieve]
  25. Murgola, E. J., Pagel, F. T., Hijazi, K. A., Arkov, A. L., Xu, W., and Zhao, S. Q. (1995) Biochem. Cell Biol. 73, 925-931[Medline] [Order article via Infotrieve]
  26. Rinke-Appel, J., Jünke, N., Brimacombe, R., Dokudovskaya, S., Dontsova, O., and Bogdanov, A. Nucleic Acids Res. 21, 2853-2859


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.